Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: A single center retrospective analysis

Treatment of locally advanced non-small-cell lung cancer is based on a combined approach. To study the impact of trimodal therapy for stage III-N2 NSCLC a single centre retrospective evaluation focusing on survival and therapy-related toxicity was performed.